IFNa17
Reactivité: Humain
WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:5000-20000
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 %BSA
Agent conservateur
ProClin
Précaution d'utilisation
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
IFNA17 (IFNa17)
(Interferon, alpha 17 (IFNa17))
Autre désignation
IFN17
Sujet
Interferon alpha-17, IFN-alpha-17, Interferon alpha-88, Interferon alpha-I', LeIF I, Interferon alpha-TIFNA17 (Interferon Alpha 17) is a Protein Coding gene. Diseases associated with IFNA17 include Adenosquamous Pancreas Carcinoma and Crimean-Congo Hemorrhagic Fever. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways. Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.